Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
0.010 Biomarker disease BEFREE Overall outcomes were comparable to those of two matched cohorts (n = 172) from previous European Vasculitis Society (EUVAS) trials, but with lower total exposure to CYC and GCs (P < 0.001) and reduced rates of severe infections (P = 0.02) compared with the RITUXVAS (rituximab versus cyclophosphamide in AAV) trial. 30239910 2019